|
|
Article: ART Advanced Research Technologies Launches Optix MX3 Molecular Imaging System at WMIC2009; Optix MX3 offers a new benchmark for imaging performance and versatility in the preclinical phases of drug development.
- Article from:
- Marketwire Canada
- Article date:
- September 23, 2009
CopyrightCOPYRIGHT 2009 Canadian Corporate News. News Provided by Comtex. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
MONTREAL, CANADA, Sep 23, 2009 (Marketwire via COMTEX) -- ART Advanced Research Technologies Inc. ("ART") (TSX:ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, today unveiled a new generation of its optical molecular imaging system, called Optix(R) MX3, at the Industry Workshop opening event of the World Molecular Imaging Congress. The event is being held this year in Montreal, Canada, from September 23 to 26. ART is also featuring the Optix(R) MX3, as well as its SoftScan(R) and Fenestra(R) product offering, as an exhibitor at the event (booth #301), in the Exhibit Hall of the ...